During the past decade, Inova Melanoma and Skin Cancer Center conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Inova Melanoma and Skin Cancer Center" are "Melanoma" (3 trials), "Non-Small Cell Lung Cancer" (1 trials) and "Urothelial Carcinoma" (1 trials). Many other conditions were trialed in "Inova Melanoma and Skin Cancer Center" in a lesser frequency.

Most popular intervention types in "Inova Melanoma and Skin Cancer Center" are "Drug" (3 trials), "Biological" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (2 trials), "CELLECTRA™ 2000" (1 trials), "Carboplatin" (1 trials), "Cisplatin" (1 trials) and "INO-5401" (1 trials). Other intervention names were less common.

The vast majority of trials in "Inova Melanoma and Skin Cancer Center" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Inova Melanoma and Skin Cancer Center". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Inova Melanoma and Skin Cancer Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Inova Melanoma and Skin Cancer Center, 2 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".